MTOR and cancer: Drugs that suppress mTOR, such as rapamycin or metformin, have been shown to suppress cancer, type 2 diabetes and other age-related diseases [65–67]; however, their ability to prevent age-related or other forms of hearing loss such as those linked to diabetes remain largely untested [68, 69].